Crizotinib atalanib 36)32-20-31/h2-17

36)32-20-31/h2-17

CAS Number: 1202916-90-2

2000 mg/kg bwt

CBDivE_000728

GO-6976 blocked neurotrophin-induced signaling and autophosphorylation of neurotrophin-specific tyrosine kinase (Trk) receptors

Crizotinib atalanib 36)32-20-31/h2-17Crizotinib, also known as PF 02341066, is an orally bioavailable agent belonging to the class of c met hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. Crizotinib was approved for treatment of some non small cell lung carcinoma (NSCLC) in the US, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in